Summary
Resistance of herpes simplex virus to acyclovir is a problem of growing clinical importance. Acyclovir-resistance can be due either to mutations in the viral thymidine kinase gene or in the viral DNA polymerase gene. Although clinical resistance has most frequently been associated with thymidine kinase alterations, heterogeneity in clinical isolates has not been addressed frequently. The potential for such heterogeneity has been emphasized by a report describing a pathogenic clinical isolate containing within its population at least one thymidine kinase-proficient DNA polymerase mutant as well as mutants exhibiting thymidine kinase-deficiency (Sacks, et al., 1989). We provide here additional characterization of this isolate and speculations regarding its significance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chatis, P.A., Miller, C.H., Schrager, L.E., and Crumpacker, C.S., 1989, Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simples virus in a patient with acquired immunodeficiency syndrome, N. Engl. J. Med. 320:297–300.
Coen, D.M., 1991, The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy, Antiviral Res., 15:287–300.
Coen, D.M., Furman, P.A., Aschman, D.P., and Schaffer, P.A., 1983, Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin, Nucleic Acids Res. 11:5287–5297.
Coen, D.M., Fleming, H.E., Jr., Leslie, L.K., and Retondo, M.J., 1985, Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus, J. Virol. 53:477–488.
Coen, D.M., and Schaffer, P.A., 1980, Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1, Proc. Natl. Acad. Sci. USA 77:2265–2269.
Collins, P., Larder, B.A., Oliver, N.M., Kemp, S., Smith, I.W., and Darby, G., 1989, Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir, J. Gen. Virol. 70:375–382.
Ellis, M.N., Waters, R., Hill, E.L., Lober, D.C., Selleseth, D.W., and Barry, D.W., 1989, Orofacial infection of athymic mice with defined mixtures of acyclovirsusceptible and acyclovir-resistant herpes simplex virus type 1, Antimicrob. Agents Chemother.
Englund, J.A., Zimmerman, M.E., Swierkosz, E.M., Goodman, J.L., Scholl, D.R., and Balfour, H.H., Jr., 1990, Herpes simplex virus resistant to acyclovir: a study in a tertiary care center, Ann. Intern. Med. 112:416–422.
Erlich, K.S., Mills, J., Chatis, P., Mertz, G.J., Busch, D.F., Follansbee, S.E., Grant, R.M., and Crumpacker, C.S., 1989, Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome, N. Engl. J. Med. 320:293–296.
Field, H.J., 1982, Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy, Antimicrob. Angent Chemother. 21:744–752.
Field, H.J., and Lay, E., 1984, Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir, Antiviral Res. 4:43–52.
Furman, P.A., St. Clair, M.H., Fyfe, J.A., Rideout, J.L., Keller, P.M., and Elion, G.B., 1979, Inhibition of herpes simplex virus induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate, J. Virol. 32:72–77.
Fyfe, J.A., Keller, P.M., Furman, P A, Miller, R.L., and Elion, G.B., 1978, Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound 9- (2-hydroxyethoxymethyl)guanine, J. Biol. Chem. 253:8721–8727.
Hicks, K.A., and Coen, D.M., unpublished results.
Krokan, H., Schaffer, P., and DePamphilis, M., 1979, Involvement of eucaryotic deoxyribonucleic acid polymerases alpha and gamma in replication of cellular and viral deoxyribonucleic acid, Biochemistry 18:4431–4443.
Larder, B.A., and Darby, G., Virus drug resistance: mechanisms and consequences, Antiviral Res. 4:1–42.
Norris, S.A., Kessler, H.A., and Fife, K.H., 1988, Severe progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS, J. Infect. Dis. 157:209–210.
Parker, A.C., Craig, J.I., Collins, P., Oliver, N., and Smith, I., 1987, Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase, Lancet 2:1461.
Pelosi, E., Tyler, K.L., Hwang, C.B.C., and Coen, D.M., manuscript in preparation.
Sacks, S.L., Wanklin, R.J., Reece, D.E., Hicks, K.A., Tyler, K.L., and Coen, D.M., 1989, Progressive esophagitis from acyclovir-resistant herpes simplex: clinical roles for DNA polymerase mutants and viral heterogeneity?, Ann. Intern. Med. 111:893–899.
Sedarati, F., Javier, R.T., and Stevens, J.G., 1988, Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains, J. Virol. 62:3037–3039.
Weller, S.K., Aschman, D.P., Sacks, W.R., Coen, D.M., and Schaffer, P.A., 1983, Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment, Virology 130:290–305.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pelosi, E., Hicks, K.A., Sacks, S.L., Coen, D.M. (1992). Heterogeneity of a Herpes Simplex Virus Clinical Isolate Exhibiting Resistance to Acyclovir and Foscarnet. In: Block, T.M., Jungkind, D., Crowell, R.L., Denison, M., Walsh, L.R. (eds) Innovations in Antiviral Development and the Detection of Virus Infections. Advances in Experimental Medicine and Biology, vol 312. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3462-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3462-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6533-4
Online ISBN: 978-1-4615-3462-4
eBook Packages: Springer Book Archive